Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer (NCT06952660)
A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER
🩺 Plain-English Summary (8th-Grade Level)
TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of cancer cells. This is done either by killing the cells or by stopping them from growing. The purpose of this study is to learn about possible side effects of TIVDAK, specially to any side effect that is related to the eye. A side effect is anything a medicine does to your body that is not part of how the medicine treats disease. * This study is seeking for participants who: Are willing to take all the required eye tests * Have not received TIVDAK before * Do not have any active eye issues. Participants will receive TIVDAK once every 3 weeks as an infusion that will be injected into the vein. Participants will visit an eye care provider at 3 stages: * before starting the treatment, * before each of the first 9 infusions * then monthly for 3 months after they stop taking TIVDAK. Treatment with TIVDAK will continue until it is not working anymore against the participant's cancer.
Who can join: Review the eligibility criteria below.
Location: HonorHealth Cancer Care - Biltmore - AZCCC Imaging — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (129 Sites)
Showing the first 25 of 129 sites.
- HonorHealth Cancer Care - Biltmore - AZCCC Imaging — Phoenix, Arizona
- HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy — Phoenix, Arizona
- HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care -Biltmore — Phoenix, Arizona
- Sonora Quest Laboratories, LLC — Phoenix, Arizona
- South West Medical Imaging (SMIL) — Phoenix, Arizona
- Schwartz Laser Eye Center — Scottsdale, Arizona
- Virginia G. Piper Cancer Pharmacy - HonorHealth Research Pharmacy — Scottsdale, Arizona
- HonorHealth Cancer Care - Tempe - AZCCC Imaging — Tempe, Arizona
- HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care - Tempe — Tempe, Arizona
- AdventHealth Hematology and Oncology Denver — Denver, Colorado
- AdventHealth Medical Group Gynecologic Oncology at Porter — Denver, Colorado
- Mount Sinai Comprehensive Cancer Center - Aventura — Aventura, Florida
- Florida Cancer Specialists — Bonita Springs, Florida
- Florida Cancer Specialists — Bradenton, Florida
- Florida Cancer Specialists — Cape Coral, Florida
- Broward Health Coral Springs — Coral Springs, Florida
- Florida Cancer Specialists — Daytona Beach, Florida
- Broward Health North — Deerfield Beach, Florida
- Florida Cancer Specialists — Fleming Island, Florida
- Broward Health Imperial Point — Fort Lauderdale, Florida
- Broward Health Medical Center — Fort Lauderdale, Florida
- Florida Cancer Specialists — Fort Myers, Florida
- Florida Cancer Specialists — Fort Myers, Florida
- HCA Mercy Hospital — Miami, Florida
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida
📞 Contact the Study Coordinator
Phone: (800) 718-1021
Email: ClinicalTrials.gov_Inquiries@pfizer.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cervical Cancer
- SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) — Ouagadougou,
- Dostarlimab and Cobolimab in Advanced Cervical Cancer — Boston, Massachusetts
- International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer — Liège,
- Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement — Houston, Texas
- Sexual Health Empowerment for Women's Health — Kansas City, Missouri
- Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique — Houston, Texas
Explore by condition: All Cervical Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.